GonarthrosisNCT03951545
Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting
A study testing First line total knee replacement for gonarthrosis . in people with Gonarthrosis, run by CHU de Reims at 1 site in France.
Trial summary
Type of study : Superiority study, comparative, randomized, double-blind (patient and evaluator will be blind from the randomization group), multicenter, prospective inclusion. Two groups of patients will be compared: a group of patients whose tibial sections will be performed using extramedullary mechanical sighting… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Gonarthrosis
- What is being tested?
- First line total knee replacement for gonarthrosis .
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 382 participants
- Where
- 1 siteFrance
- Study dates
- 21 Nov 2018to 21 Aug 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Gonarthrosis
- Hip Knee Angle between 170° and 183°
- Agreed to participate in the study
Who cannot join
- Already undergone surgery on the same knee:
- Uni-compartmental prosthesis
- Total Knee Replacement
- Tibial or femoral osteotomy for re-alignment
- Vicious calls
Trial locations and contacts
1 site in 1 country.
Guillaume BRESSY contact
France1 site, 1 recruiting
- Recruiting
Damien JOLLY
Reims
Renaud SIBONI, 03 26 78 88 85 ext. 0033, rsiboni@chu-reims.fr
About this study
Official title: Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting : a Randomized Prospective Study
Type of study :
Superiority study, comparative, randomized, double-blind (patient and evaluator will be blind from the randomization group), multicenter, prospective inclusion. Two groups of patients will be compared: a group of patients whose tibial sections will be performed using extramedullary mechanical sighting and a group whose tibial sections will be performed using gyroscopic and accelerometric navigation (I-Assist) will be randomized. Randomization will be performed with a 1/1 ratio per block.
Read more
Population :
Patients requiring 1st line total knee replacement for gonarthrosis with a Hip knee angle (HKA) between 170° and 183° who have agreed to participate in the study. Patients who have already undergone surgery on the same knee (uni-compartmental prosthesis, total knee replacement, tibial or femoral osteotomy for re-alignment, with the exception of arthroscopy) or who have vicious calls will not be included in the study.
The number of subjects required was calculated using NQUERY 4.0 software for the main endpoint data, with the following assumptions: 51% of patients reaching the tibial cut target angles for the "extramedullary mechanical aiming" technique and 68% of patients reaching the tibial cut target angles for the I-Assist gyroscopic and accelerometric navigation technique. With an alpha risk of 5%, a power of 90%, and bilateral test, the number was estimated at 174 per group. Taking into account a percentage of included patients for whom total knee arthroplasty will not be performed of 10%, it is planned to include a total of 382 patients.
Main judgment criteria :
Achievement of the target tibial slope of 3°+/-2° and the target tibial varus/valgus at +/-2°. The tibial slope is defined by the angle (in degrees) between the mechanical axis of the tibia in profile and the tangent to the tibial cut. The varus/valgus tibial is the angle formed between the mechanical axis of the front tibia and the tangent to the tibial cut.
Investigation plan :
Proposal to participate in the research to any eligible patient at the time of a preoperative consultation with the orthopaedic surgeon. If the patient agrees to participate in the research (signature of the informed consent form), a randomization will be performed to determine the group of bone cutting technique. The patient will be blind to the result of randomization.
The clinical follow-up of the patient will not be modified by the study, with as usual:
- A 6-week consultation with interrogation, clinical and radiographic examination (Face and profil x-rays, axial patella views)
- A 3-month consultation with interrogation, clinical and radiographic examination (Face and profil x-rays, axial patella views, telemetry of the lower limbs in charge and full profile leg x-rays).
- Measurements of the radiographic judgement criteria will be performed by two orthopaedic surgeons and a blind radiologist of the cutting technique used. The tibial slope will be analyzed on the entire leg radiograph in profile at 3 months. Coronal alignment will be studied on telemetry of the front lower limbs loaded at 3 months.
- Joint amplitudes and patient satisfaction will be assessed at 3 months postoperatively with the New IKS score, by a blind surgeon of the surgical technique used.
Statistical analysis plan :
- Comparison of the characteristics of the 2 groups
- Analysis of the main endpoint: comparison of the percentage of patients with the target tibial slope achieved in both groups by Chi2 test or an accurate Fisher test, depending on the application conditions.
- Analysis of secondary judgment criteria by Student, Wilconxon, Chi2 or exact Fisher tests, depending on the application conditions.
- Conditions
- Gonarthrosis
- Being tested
- First line total knee replacement for gonarthrosis .
- Keywords
- Osteoarthritis Knee, Knee prosthesis, Patient satisfaction
- Medical subject headings
- Osteoarthritis, Knee, Patient Satisfaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
First line total knee replacement for gonarthrosis .Procedure or surgery
Patients requiring 1st line total knee replacement for gonarthrosis with a Hip knee angle (HKA) between 170° and 183°. In the first group (Mechanical) the total knee replacement will be performed with a tibial cut by using extramedullary mechanical sighting and in the second group (Gyroscopic) by using gyroscopic and accelerometric navigation (I-Assist).
| Study group | Role | What they receive |
|---|---|---|
| Mechanical group | Active comparator | Group of patients whose tibial sections will be performed using extramedullary mechanical sighting Receives: Procedure: First line total knee replacement for gonarthrosis . |
| Gyroscopic group | Experimental | Group whose tibial sections will be performed using gyroscopic and accelerometric navigation (I-Assist) will be randomized Receives: Procedure: First line total knee replacement for gonarthrosis . |
What is being measured
The primary outcome is the main question the study is designed to answer.
Achievement of the target tibial slope and the target tibial varus/valgus
Achievement of the target tibial slope of 3° +/- 2° and the target tibial varus/valgus +/- 2°. The tibial slope is defined by the angle (in degrees) between the mechanical axis of the tibia in profile and the tangent to the tibial cut. The tibial varus/valgus is the angle formed between the mechanical axis of the front tibia and the tangent to the tibial cut. This radiological evaluation is a usual assessment used in the follow-up of patients operated for a total knee replacement.
Measured: 3 months
Secondary outcomes (2)
Achievement of target global coronal alignement
Achievement of the global coronal alignment target +/- 3° defined in the preoperative pase. Coronal alignment is defined by the HKA angle, the angle (in degrees) between the center of the femoral head, the center of the knee and the center of the tibio-fibluar mortise. This radiological evaluation is a usual assessment used in the follow-up of patients operated for a total knee replacement.
Measured: 3 months
Patient satisfaction: New IKS score
Patient satisfaction will be assessed using the New International Knee Society score (New IKS score) collected by a blind investigator.
The new IKS score was validated in French in 2014 (Debette C, Parratte S, Maucort-Boulch D, Blanc G, Pauly V, Lustig S, Servien E, Neyret P, Argenson JN.
French adaptation of the new Knee Society Scoring System for total knee arthroplasty. Orthop Traumatol Surg Res. 2014 Sep;100(5):531-4.) New IKS score range from 0 to 200 with a physical score on 100 points (pain, knee' mobility, abnormal laxity, flexion deformity and Hips knee Ankle) and a functional score on 100 points (walking distance, difficulty with stairs and use of walking aids).
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2019
- Study start21 Nov 2018
- Primary completion21 Feb 2021 (estimated)
- Study completion21 Aug 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GonarthrosisStudies of the same condition, open and under way.
- More trials run by CHU de ReimsThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 382 participants (estimated)
Sponsor and investigators
- Lead sponsor
- CHU de Reims
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03951545
- Sponsor's protocol ID
- PO18142
- Status last verified
- Dec 2018
- First submitted
- 7 Nov 2018
- Last updated
- 15 May 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 May 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting : a Randomized Prospective Study
- ClinicalTrials.gov ID
- NCT03951545
- Acronym / sponsor ID
- PO18142
- Conditions
- Gonarthrosis
- Keywords
- Osteoarthritis Knee, Knee prosthesis, Patient satisfaction
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 382 participants (estimated)
- Lead sponsor
- CHU de ReimsUniversity, hospital or other
- Study start
- 21 Nov 2018 (actual)
- Primary completion
- 21 Feb 2021 (estimated)
- Study completion
- 21 Aug 2021 (estimated)
- First posted
- 15 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Type of study :
Superiority study, comparative, randomized, double-blind (patient and evaluator will be blind from the randomization group), multicenter, prospective inclusion. Two groups of patients will be compared: a group of patients whose tibial sections will be performed using extramedullary mechanical sighting and a group whose tibial sections will be performed using gyroscopic and accelerometric navigation (I-Assist) will be randomized. Randomization will be performed with a 1/1 ratio per block.
Population :
Patients requiring 1st line total knee replacement for gonarthrosis with a Hip knee angle (HKA) between 170° and 183° who have agreed to participate in the study. Patients who have already undergone surgery on the same knee (uni-compartmental prosthesis, total knee replacement, tibial or femoral osteotomy for re-alignment, with the exception of arthroscopy) or who have vicious calls will not be included in the study.
The number of subjects required was calculated using NQUERY 4.0 software for the main endpoint data, with the following assumptions: 51% of patients reaching the tibial cut target angles for the "extramedullary mechanical aiming" technique and 68% of patients reaching the tibial cut target angles for the I-Assist gyroscopic and accelerometric navigation technique. With an alpha risk of 5%, a power of 90%, and bilateral test, the number was estimated at 174 per group. Taking into account a percentage of included patients for whom total knee arthroplasty will not be performed of 10%, it is planned to include a total of 382 patients.
Main judgment criteria :
Achievement of the target tibial slope of 3°+/-2° and the target tibial varus/valgus at +/-2°. The tibial slope is defined by the angle (in degrees) between the mechanical axis of the tibia in profile and the tangent to the tibial cut. The varus/valgus tibial is the angle formed between the mechanical axis of the front tibia and the tangent to the tibial cut.
Investigation plan :
Proposal to participate in the research to any eligible patient at the time of a preoperative consultation with the orthopaedic surgeon. If the patient agrees to participate in the research (signature of the informed consent form), a randomization will be performed to determine the group of bone cutting technique. The patient will be blind to the result of randomization.
The clinical follow-up of the patient will not be modified by the study, with as usual:
- A 6-week consultation with interrogation, clinical and radiographic examination (Face and profil x-rays, axial patella views)
- A 3-month consultation with interrogation, clinical and radiographic examination (Face and profil x-rays, axial patella views, telemetry of the lower limbs in charge and full profile leg x-rays).
- Measurements of the radiographic judgement criteria will be performed by two orthopaedic surgeons and a blind radiologist of the cutting technique used. The tibial slope will be analyzed on the entire leg radiograph in profile at 3 months. Coronal alignment will be studied on telemetry of the front lower limbs loaded at 3 months.
- Joint amplitudes and patient satisfaction will be assessed at 3 months postoperatively with the New IKS score, by a blind surgeon of the surgical technique used.
Statistical analysis plan :
- Comparison of the characteristics of the 2 groups
- Analysis of the main endpoint: comparison of the percentage of patients with the target tibial slope achieved in both groups by Chi2 test or an accurate Fisher test, depending on the application conditions.
- Analysis of secondary judgment criteria by Student, Wilconxon, Chi2 or exact Fisher tests, depending on the application conditions.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mechanical group | Active comparator | Procedure: First line total knee replacement for gonarthrosis .Group of patients whose tibial sections will be performed using extramedullary mechanical sighting |
| Gyroscopic group | Experimental | Procedure: First line total knee replacement for gonarthrosis .Group whose tibial sections will be performed using gyroscopic and accelerometric navigation (I-Assist) will be randomized |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Gonarthrosis
- Hip Knee Angle between 170° and 183°
- Agreed to participate in the study
Key exclusion criteria (5 listed)
- Already undergone surgery on the same knee:
- Vicious calls
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| First line total knee replacement for gonarthrosis .Patients requiring 1st line total knee replacement for gonarthrosis with a Hip knee angle (HKA) between 170° and 183°. In the first group (Mechanical) the total knee replacement will be performed with a tibial cut by using extramedullary mechanical sighting and in the second group (Gyroscopic) by using gyroscopic and accelerometric navigation (I-Assist). | Procedure or surgery | Gyroscopic group, Mechanical group |
Primary outcome
Achievement of the target tibial slope and the target tibial varus/valgus
Time frame: 3 months
Achievement of the target tibial slope of 3° +/- 2° and the target tibial varus/valgus +/- 2°. The tibial slope is defined by the angle (in degrees) between the mechanical axis of the tibia in profile and the tangent to the tibial cut. The tibial varus/valgus is the angle formed between the mechanical axis of the front tibia and the tangent to the tibial cut. This radiological evaluation is a usual assessment used in the follow-up of patients operated for a total knee replacement.
2 secondary outcomes
Achievement of target global coronal alignement
Time frame: 3 months
Patient satisfaction: New IKS score
Time frame: 3 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 May 2019.
Related trials for Gonarthrosis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Guillaume BRESSY contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing First line total knee replacement for gonarthrosis . in people with Gonarthrosis, run by CHU de Reims at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 May 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Renaud SIBONI (03 26 78 88 85 ext. 0033, rsibony@chu-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Achievement of the target tibial slope and the target tibial varus/valgus (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2019.